» Articles » PMID: 26296235

Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy

Abstract

Background: Russell's viper envenoming is a major problem in South Asia and causes venom induced consumption coagulopathy. This study aimed to investigate the kinetics and dynamics of venom and clotting function in Russell's viper envenoming.

Methodology/principal Findings: In a prospective cohort of 146 patients with Russell's viper envenoming, we measured venom concentrations, international normalised ratio [INR], prothrombin time (PT), activated partial thromboplastin time (aPTT), coagulation factors I, II, V, VII, VIII, IX and X, and von Willebrand factor antigen. The median age was 39 y (16-82 y) and 111 were male. The median peak INR was 6.8 (interquartile range [IQR]: 3.7 to >13), associated with low fibrinogen [median,<0.01 g/L; IQR: <0.01-0.9 g/L), low factor V levels [median,<5%; IQR: <5-4%], low factor VIII levels [median,40%; IQR: 12-79%] and low factor X levels [median, 48%; IQR: 29-67%]. There were smaller reductions in factors II, IX and VII over time. All factors recovered over 48 h post-antivenom. The median INR remained >3 at 6 h post-antivenom but had reduced to <2, by 24 h. The aPTT had also returned to close to normal (<50 sec) at 24 h. Factor VII, VIII and IX levels were unusually high pre-antivenom, median peak concentrations of 393%, 307% and 468% respectively. Pre-antivenom venom concentrations and the INR (r = 0.20, p = 0.02) and aPTT (r = 0.19, p = 0.03) were correlated (non-parametric Spearman analysis).

Conclusions: Russell's viper coagulopathy results in prolonged aPTT, INR, low fibrinogen, factors V, VIII and X which recover over 48 h. Severity of clotting abnormalities was associated with venom concentrations.

Citing Articles

Clinical Characteristics of Snakebite Envenomings in Taiwan.

Mao Y, Liu P, Lai K, Luo Y, Chen K, Lai C Toxins (Basel). 2025; 17(1).

PMID: 39852967 PMC: 11769513. DOI: 10.3390/toxins17010014.


Peripheral Arterial Thrombosis following Russell's Viper Bites.

Senthilkumaran S, Patel K, Rajan E, Vijayakumar P, Miller S, Rucavado A TH Open. 2023; 7(2):e168-e183.

PMID: 37333023 PMC: 10276757. DOI: 10.1055/s-0043-1769625.


Proteomic Analysis, Immuno-Specificity and Neutralization Efficacy of Pakistani Viper Antivenom (PVAV), a Bivalent Anti-Viperid Antivenom Produced in Pakistan.

Lim A, Tan K, Quraishi N, Farooque S, Khoso Z, Ratanabanangkoon K Toxins (Basel). 2023; 15(4).

PMID: 37104203 PMC: 10145215. DOI: 10.3390/toxins15040265.


Factor assay in victims of snake bite: Experience from a tertiary care institute in South India.

Rafi A, Innah S Asian J Transfus Sci. 2023; 16(2):175-179.

PMID: 36687535 PMC: 9855208. DOI: 10.4103/ajts.AJTS_104_18.


D-dimer testing for early detection of venom-induced consumption coagulopathy after snakebite in Australia (ASP-29).

Isbister G, Noutsos T, Jenkins S, Isoardi K, Soderstrom J, Buckley N Med J Aust. 2022; 217(4):203-207.

PMID: 35670073 PMC: 9541317. DOI: 10.5694/mja2.51589.


References
1.
Rosing J, Yukelson L, Tans G . Factor V activation and inactivation by venom proteases. Haemostasis. 2002; 31(3-6):241-6. DOI: 10.1159/000048069. View

2.
Tans G, Rosing J . Snake venom activators of factor X: an overview. Haemostasis. 2002; 31(3-6):225-33. DOI: 10.1159/000048067. View

3.
Kini R, Rao V, Joseph J . Procoagulant proteins from snake venoms. Haemostasis. 2002; 31(3-6):218-24. DOI: 10.1159/000048066. View

4.
Triplett D . Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls. J Autoimmun. 2000; 15(2):173-8. DOI: 10.1006/jaut.2000.0414. View

5.
Takeya H, Nishida S, Miyata T, Kawada S, Saisaka Y, Morita T . Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J Biol Chem. 1992; 267(20):14109-17. View